A Phase 0 Trial of Riluzole in Patients with Resectable Stage III and IV Melanoma

PURPOSE: Ectopic expression of GRM1 in murine melanocytes results in transformation into a form of melanoma, and more than 60% of human melanoma samples tested ectopically express GRM1. Stimulation of this receptor in vitro results in up-regulation of activated extracellular signal–regulated kinase...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yip, Dana, Le, Maithao N., Chan, Joseph L.-K., Lee, Jonathan H., Mehnert, Janice A., Yudd, Anthony, Kempf, Jeffery, Shih, Weichung J., Chen, Suzie, Goydos, James S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2812866/
https://ncbi.nlm.nih.gov/pubmed/19458050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-3303
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados